With your permission, we use privacy-limited analytics to understand which research journeys work. We do not run advertising trackers or session replay. You can change this choice in Preferences. Read the Privacy Policy.
Educational research only - not investment advice, an offer, or a trade instruction. Confirm current data and do your own due diligence before acting.
WMT trades against a final fair-value range of $46.19-$71.92, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs.
WMT's base cash generation remains robust with $17.2B FCFFFree cash flow to firmCash flow available to all capital providers (debt and equity) before financing costs. Discounted at WACC to derive enterprise value. absorbing $21.4B capexCapital expendituresCash spent on acquiring or upgrading property, plant, and equipment. Splits into maintenance capex (sustaining current capacity) and growth capex (expanding capacity).. The primary stress is entirely valuation-driven; the stock is priced for tech-like structural margin expansion. Reversion in terminal multipleTerminal multipleThe exit P/E or EV/EBITDA we apply to the final year of an explicit forecast. Anchored to the business's long-run quality and the prevailing risk-free rate. to 22x slashes equity value by over 50% without a single fundamental misstep.
Market rotation forces WMT's ~40x forward P/E back to its historical 22x mature retail average, vaporizing multiple-driven equity value.
Persistent wage inflation and e-commerce fulfillment costs permanently compress operating margins below the 4.5% baseline, destroying long-term FCF yield.
Severe macroeconomic weakness forces extreme trade-down behavior, triggering aggressive promotional environments that strip away gross margin gains.
| Line item | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | 2026-01-31 | Trend |
|---|---|---|---|---|---|---|
| Revenue | $572.75B | $611.29B+6.7% | $648.13B+6.0% | $680.99B+5.1% | $713.16B+4.7% | +5.6% |
| Gross profit | $143.75B | $147.57B | $157.98B | $169.23B | $177.77B | +5.5% |
| Operating income | $25.94B | $20.43B | $27.01B | $29.35B | $29.83B | +3.5% |
| Net income | $13.67B | $11.68B-14.6% | $15.51B+32.8% | $19.44B+25.3% | $21.89B+12.6% | +12.5% |
| EPS (diluted) | $1.62 | $1.42 | $1.91 | $2.41 | $2.73 | +13.9% |
| EBITDA | $31.35B | $30.09B | $36.38B | $42.01B | $46.47B | +10.3% |
| R&D | — | — | — | — | — | — |
| SG&A | $117.81B | $127.14B | $130.97B | $139.88B | — | +4.4% |
Cash-flow quality is reflected in the OCFOperating cash flowCash generated from the company's core operations after working-capital changes but before capital expenditures. The first line of the cash-flow statement. / net incomeNet IncomeNet Income is an income-statement line item used to reconcile revenue to operating profit, pre-tax income, net income, or per-share earnings. It should be compared across periods and against peer disclosure conventions., accounting-quality, and ROICROICReturn on invested capital. Operating profit (after tax) divided by invested capital. The single best gauge of capital-efficiency. Spread over WACC = economic value created. rows above.
Capital allocation should be evaluated against reinvestment needs, balance-sheet strength, and shareholder returns.
| Deterioration versus the report thesis |
| Capex-to-revenue ratio exceeding 5% without corresponding ROIC expansion. | Monitor | Deterioration versus the report thesis |
| Market rotation out of defensive staples compressing sector multiples. | Monitor | Deterioration versus the report thesis |
